Charles Achkar

Title: Charles Achkar: Innovator in Gene Expression Regulation

Introduction

Charles Achkar is a notable inventor based in North Bergen, NJ (US). He holds 2 patents that focus on the innovative use of retinoids in regulating gene expression. His work has significant implications for medical treatments, particularly in oncology and dermatology.

Latest Patents

Achkar's latest patents involve the use of specific retinoids with a side chain terminal CH.sub.2 OH group or its derivatives. For the first time, these compounds have been shown to bind to nuclear receptors and induce cell differentiation in both normal and tumor cells. This groundbreaking research indicates that these retinoids can activate gene expression through their interaction with nuclear receptor proteins. The compounds are particularly useful in treating conditions such as leukemias, lymphomas, squamous cell carcinomas, deep (cystic) acne, psoriasis, and photodamaged or aging skin. They also demonstrate stability and in vitro half-life advantages over all-trans-retinoic acid, along with activity advantages over 13-cis retinoic acid.

Career Highlights

Throughout his career, Charles Achkar has contributed significantly to the field of gene expression and its applications in medicine. His innovative research has paved the way for new therapeutic approaches in treating various diseases.

Collaborations

Achkar has collaborated with esteemed institutions such as Cornell University and Columbia University. He has also worked alongside notable colleagues, including Alexander W. Langston and Fadila Derguini.

Conclusion

Charles Achkar's contributions to the field of gene expression regulation through retinoids highlight his role as a significant innovator. His work continues to influence medical research and treatment options for various health conditions.